ArticleCancers2023

Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy.

Haosheng Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.